Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2 — Stella

Home/Influenza/

View on ClinicalTrials.gov

Recruiting

Back to Influenza trials

Trial locations(1 site)

United States

Washington University in Saint Louis Department of Emergency Medicine, Emergency Care Research Core, St Louis, Missouri

Key details

Sponsor

Washington University School of Medicine

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment target

~300 participants

Started

March 2025

Primary completion

April 2029

Age range

18 Years – 60 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.